Demierre M F, Goldberg L J, Kadin M E, Koh H K
Department of Dermatology, Boston University School of Medicine, MA, USA.
J Am Acad Dermatol. 1997 May;36(5 Pt 1):765-72. doi: 10.1016/s0190-9622(97)80330-1.
Distinguishing malignancy from premalignant conditions can be difficult. Controversy surrounds both the clinical and histologic criteria used to distinguish lymphomatoid papulosis, a benign disorder, from CD30+ anaplastic large-cell lymphoma. Three case histories illustrate important points in categorizing different lymphoproliferative disorders as benign or malignant. We emphasize a multidisciplinary approach to improve diagnosis and patient management.
区分恶性肿瘤与癌前病变可能具有挑战性。围绕用于区分良性疾病淋巴瘤样丘疹病与CD30 +间变性大细胞淋巴瘤的临床和组织学标准存在争议。三个病例史说明了将不同淋巴增殖性疾病归类为良性或恶性的要点。我们强调采用多学科方法来改善诊断和患者管理。